Ensuring AAV Characterization and Comparability Using Reliable AAV Reference Material
Gene therapy is transforming treatment paradigms, with AAV vectors at the forefront of clinical innovation. This webinar will highlight the critical need for robust AAV characterization and comparability, focusing on the use of high-quality, well-defined AAV reference materials.
Learn how these premium tools support accurate titer determination, capsid integrity analysis, and lot-to-lot consistency—key factors in regulatory submissions and therapeutic success. Join us to explore technical strategies that elevate AAV assay performance and standardization.
Joshua Baal – Product Manager, PROGEN
Joshua Baal holds a Master in Molecular Cell Biology and has several years of hands-on industry experience. Before joining PROGEN as a Product Manager, he worked four years as an ecotoxicologist specializing in plant protection product registration.
At PROGEN, Joshua oversees a broad portfolio of antibodies and related products, focusing on advancing gene therapy tools and standards.
Get chance to learn:
- Recognize the critical role of highly characterized AAV standards for ensuring accuracy, reproducibility, and regulatory compliance in gene therapy analytics
- Understand the role of AAV standards in the full/empty characterization
- Delve into the factors that influence the comparability of capsid titers between orthogonal methods
Jacintha Victoria – Market Development Manager (CGT), Refeyn
Jacintha Victoria is a strategic marketing and analytical leader with over a decade of experience in the biotechnology and gene therapy sectors. As the Market Development Manager at Refeyn Ltd. in Oxford, UK, she leads initiatives/ campaigns to drive the adoption of Mass Photometry across critical applications in cell and gene therapy, including AAV, LVV, adenovirus, and RNA-based platforms.
With a deep understanding of the emerging analytical technologies, Jacintha advocates for Mass Photometry as a transformative tool to enhance viral vector characterization, accelerate product development, and strengthen regulatory preparedness.
She holds a Master of Science in Cellular and Molecular Biology from the University of New Haven and is certified as a Technologist in Molecular Biology by the ASCP. Passionate about bridging science and strategy, Jacintha is dedicated to advancing innovative therapeutic solutions through data-driven marketing, cross-functional collaboration, and thought leadership
Get chance to learn:
- Understand Mass Photometry as a single-molecule technique for directly measuring the mass of AAV viral vectors
- Compare Mass Photometry to orthogonal methods commonly used in the industry
- Explore how SamuxMP enables accurate and reliable characterization of heterogeneous AAV samples, supporting robust process monitoring and product quality control